Showing 15 posts of 17 posts found.


BioNTech seek approval for COVID-19 vaccine in children aged 5-11

September 13, 2021
Sales and Marketing COVID-19, FDA, Vaccine, children

Children between 5 and 11 years old are to be targeted by BioNTech as the company seeks approval for younger …

UK COVID vaccine update

June 16, 2021
Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …


Teva launch generic version of EpiPen for children

August 21, 2019
Research and Development Mylan, Teva, allergies, children, epipen, pharma

A generic version of Mylan’s EpiPen, manufactured by Teva, is now available for children weighing between 15kg and 30kg in …

Children wait six and half years longer than adults for new cancer drugs, study says

May 22, 2019
Research and Development Cancer, FDA, children, oncology, paediatrics, pharma

Children wait six and half years longer than adults to access new cancer drugs, according to a study from Dana-Farber/Boston …


Children born in poverty show major differences in brain function, study shows

April 3, 2019
Research and Development India, UEA, brain development, brain function, childhood, children

Children born into poverty show major differences in early brain function, according to research from the University of East Anglia. …

Postoperative radiation can triple survival in children with brain cancer

March 6, 2019
Research and Development brain cancer, children, epndymoma, oncology, paediatric brain cancer, radiation

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …

Probiotics have no effect on children with gastroenteritis, study shows

November 22, 2018
Research and Development children, flu, gastroenteritis, probiotics, research

Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …

More children suffering from type 2 diabetes in England and Wales

August 20, 2018
Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …

Drugs should be preferred first-choice treatment for ADHD

August 8, 2018
Research and Development ADHD, adults, amphetmines, children, prescription, ritalin

Ritalin and other amphetamines should be the preferred first-choice medications for the short-term treatment of ADHD, according to a study …

More antidepressants being prescribed to children in UK

July 25, 2018
Research and Development antidepressants, children, mental health, prescription, young people

Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …


Surprising number of parents agree to use of placebos in children

November 16, 2016
Medical Communications, Research and Development Placebo, children

A study by Boston Children’s Hospital found that parents recognised that placebos are a vital part of research and that …

Promising new study for children’s brain cancer

November 1, 2016
Manufacturing and Production brain cancer, children, oncology

There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …


Second child cleared of leukaemia after Cellectis T-cell treatment

May 10, 2016
Manufacturing and Production, Research and Development cellecits, childhood, children, designer cells, leukaemia, rare, t cells, t-cells

A targeted T-cell oncology therapy has successfully treated a second baby with aggressive leukaemia who has remained in remission after …


Amgen’s drug reduces rates of bleeding in rare childhood disorder

April 21, 2016
Research and Development, Sales and Marketing Amgen, blood disorder, children, nplate, paediatric, platelet, rare, romisplostim

Amgen (NASDAQ: AMGN) has announced the results of a Phase III trial, published in The Lancet, which shows that Nplate …

Novartis receives EU approval for blood disorder treatment in children

April 7, 2016
Research and Development, Sales and Marketing EMA, EU, ITP, Novartis, Revolade, approval, blood disorder, children, chronic itp

Novartis (NYSE: NVS) has announced that Revolade (eltrombopag) has been approved in the EU for use in paediatric patients aged …

Latest content